share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director FREYMAN THOMAS C

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director FREYMAN THOMAS C

艾伯维公司 | 4：持股变动声明-董事 FREYMAN THOMAS C
美股sec公告 ·  05/07 18:36
Moomoo AI 已提取核心信息
Thomas C. Freyman, associated with AbbVie Inc. [ABBV], completed a transaction on May 3, 2024, acquiring 1,322 shares of common stock at no cost. Following this transaction, Freyman's direct holdings in AbbVie amount to 125,548 shares. Additionally, indirect holdings through family trusts total 7,882 shares, with 4,000 held by a spouse in trust and 3,882 held by a spouse as trustee for their son. The transaction has been marked as completed.
Thomas C. Freyman, associated with AbbVie Inc. [ABBV], completed a transaction on May 3, 2024, acquiring 1,322 shares of common stock at no cost. Following this transaction, Freyman's direct holdings in AbbVie amount to 125,548 shares. Additionally, indirect holdings through family trusts total 7,882 shares, with 4,000 held by a spouse in trust and 3,882 held by a spouse as trustee for their son. The transaction has been marked as completed.
与艾伯维公司 [ABBV] 相关的托马斯·弗雷曼于2024年5月3日完成了一项交易，免费收购了1,322股普通股。在这笔交易之后，弗雷曼在艾伯维的直接持股量为125,548股。此外，通过家族信托间接持有的股票共计7,882股，其中4,000股由配偶信托持有，3,882股由配偶作为子子的受托人持有。该交易已标记为已完成。
与艾伯维公司 [ABBV] 相关的托马斯·弗雷曼于2024年5月3日完成了一项交易，免费收购了1,322股普通股。在这笔交易之后，弗雷曼在艾伯维的直接持股量为125,548股。此外，通过家族信托间接持有的股票共计7,882股，其中4,000股由配偶信托持有，3,882股由配偶作为子子的受托人持有。该交易已标记为已完成。
有用
没用

该公告为独立文件：

独立文件1

独立文件2

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息